SageView Advisory Group’s Bio-Techne TECH Stock Holding History

SageView Advisory Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,266	Closed	-$74.5K	–	2237
2025 Q4	$74.5K	Buy	+1,266	New	+$76.9K	﹤0.01%	922

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SageView Advisory Group's TECH Position: Q1 2026 in Review

SageView Advisory Group sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 1,266 shares — an estimated $74.5K sold.

SageView Advisory Group first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $74.5K in Q4 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

SageView Advisory Group reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 1,266 Bio-Techne shares in Q1 2026, an estimated $74.5K.
SageView Advisory Group first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Bio-Techne position peaked at $74.5K in Q4 2025.
585 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.